SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-071078
Filing Date
2024-06-13
Accepted
2024-06-13 08:36:13
Documents
17
Period of Report
2024-06-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2417173d1_8k.htm   iXBRL 8-K 37967
2 EXHIBIT 4.1 tm2417173d1_ex4-1.htm EX-4.1 70167
3 EXHIBIT 10.1 tm2417173d1_ex10-1.htm EX-10.1 226057
4 EXHIBIT 10.2 tm2417173d1_ex10-2.htm EX-10.2 115398
5 EXHIBIT 99.1 tm2417173d1_ex99-1.htm EX-99.1 12043
  Complete submission text file 0001104659-24-071078.txt   743798

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA repl-20240612.xsd EX-101.SCH 3018
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE repl-20240612_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE repl-20240612_pre.xml EX-101.PRE 22361
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2417173d1_8k_htm.xml XML 3683
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38596 | Film No.: 241040082
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)